Clinical trials of psychedelics creates a patent gold rush
October 25, 2022
A growing number of companies are filing patent applications for natural and synthetic psychedelics encouraged by clinical trials providing evidence that their use may be helpful in treating a wide variety of mental health issues and other medical conditions. Robin Feldman, a professor at the University of California Hastings College of Law, expressed concerns about the gold rush mentality. “It’s not pretty when you look under the hood,” she said. “With psychedelics, what we’re seeing is a clash of cultures between the altruism of those who want to use existing compounds in new and exciting ways crashing up against the realities of the patent system.”
Recent News
Study Finds That Chemicals Inside Cars Can Cause Cancer
Flame retardants are added to vehicle interiors, but contain disease-causing agents.
Amazon Beauty’s Summer Beauty Haul Returns
As the summer approaches, Amazon Beauty is rolling out its much-anticipated Summer Beauty Haul.
Popular Sriracha Sauce to Cut Production This Summer
The popular condiment may be tougher to find than ever.
Cyberattack Disrupts Ascension Healthcare, Ambulances Diverted
A significant cyberattack has struck the core of the U.S. healthcare system, sending shockwaves through Ascension, a nonprofit network encompassing 140 hospitals across 19 states.